EUVIMEDEUVIMED entdecken
VergleichsstudieÜbersichtsarbeit

Obesity and Cardiovascular Disease: Pathogenic Mechanisms and Potential Benefits of Weight Reduction

James D Douketis, Arya M Sharma

Seminars in Vascular Medicine · 01.01.2005 · 5 (01) · 25-33

DOI: 10.1055/s-2005-871739 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Seminars in Vascular Medicine, erschienen am 01.01.2005. Verfasst von James D Douketis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Weight Loss. Die Arbeit wurde bisher 55-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of obesity in industrialized countries has reached epidemic proportions, with about one in three people being obese and another one in three people being overweight and at risk of developing obesity. In recent years, obesity has gained the traditional tetrad of cardiovascular risk factors of smoking: hypertension, dyslipidemia, and dysglycemia. Attention has also focused on the importance of abdominal (or central) obesity as a determinant of cardiovascular risk, independent of the body mass index. In addition to effects on coronary artery disease, obesity has an effect on cardiovascular disease, including stroke, ventricular function, peripheral arterial disease, and venous thromboembolism. The objectives of this review are to summarize the effects of obesity on cardiovascular disease, and the possible mechanisms for these associations, and to investigate the effects of weight-loss interventions on the burden of cardiovascular disease. Large ongoing clinical outcome trials, such as the SOS study, the Look-AHEAD trial, or the SCOUT study, should provide important information on the effects of surgical and nonsurgical obesity treatment on cardiovascular morbidity and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Weight LossAdultAge DistributionAgedBody Mass IndexCardiovascular DiseasesCombined Modality TherapyComorbidityDiet, ReducingExerciseFemaleHumansLactonesLife StyleMaleMiddle AgedObesityOrlistatPrevalencePrognosisRandomized Controlled Trials as Topic

Substanzen

LactonesOrlistat

Autor:innen und Institutionen

  • Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Zitieren

APA

Douketis, J. D., & Sharma, A. M. (2005). Obesity and Cardiovascular Disease: Pathogenic Mechanisms and Potential Benefits of Weight Reduction. Seminars in Vascular Medicine, 5(01), 25-33. https://doi.org/10.1055/s-2005-871739

Vancouver

Douketis JD, Sharma AM. Obesity and Cardiovascular Disease: Pathogenic Mechanisms and Potential Benefits of Weight Reduction. Seminars in Vascular Medicine. 2005;5(01):25-33. doi:10.1055/s-2005-871739

BibTeX
@article{Douketis2005,
  author = {Douketis, James D and Sharma, Arya M},
  title = {Obesity and Cardiovascular Disease: Pathogenic Mechanisms and Potential Benefits of Weight Reduction},
  journal = {Seminars in Vascular Medicine},
  year = {2005},
  volume = {5},
  number = {01},
  pages = {25--33},
  doi = {10.1055/s-2005-871739}
}
Kostenlos starten →